-
Je něco špatně v tomto záznamu ?
Caffeine and cardiovascular diseases: critical review of current research
A. Zulli, RM. Smith, P. Kubatka, J. Novak, Y. Uehara, H. Loftus, T. Qaradakhi, M. Pohanka, N. Kobyliak, A. Zagatina, J. Klimas, A. Hayes, G. La Rocca, M. Soucek, P. Kruzliak,
Jazyk angličtina Země Německo
Typ dokumentu časopisecké články, přehledy
NLK
ProQuest Central
od 1999-01-01 do 2017-12-31
CINAHL Plus with Full Text (EBSCOhost)
od 2006-02-01 do Před 1 rokem
Medline Complete (EBSCOhost)
od 1999-02-01 do Před 1 rokem
Nursing & Allied Health Database (ProQuest)
od 1999-01-01 do 2017-12-31
Health & Medicine (ProQuest)
od 1999-01-01 do 2017-12-31
Family Health Database (ProQuest)
od 1999-01-01 do 2017-12-31
Public Health Database (ProQuest)
od 1999-01-01 do 2017-12-31
- MeSH
- cévy účinky léků metabolismus MeSH
- kardiovaskulární nemoci epidemiologie MeSH
- káva škodlivé účinky chemie MeSH
- klinická studie jako téma MeSH
- kofein aplikace a dávkování škodlivé účinky MeSH
- lidé MeSH
- metaanalýza jako téma MeSH
- metabolický syndrom epidemiologie MeSH
- modely nemocí na zvířatech MeSH
- srdce účinky léků fyziologie MeSH
- vztah mezi dávkou a účinkem léčiva MeSH
- zvířata MeSH
- Check Tag
- lidé MeSH
- zvířata MeSH
- Publikační typ
- časopisecké články MeSH
- přehledy MeSH
Caffeine is a most widely consumed physiological stimulant worldwide, which is consumed via natural sources, such as coffee and tea, and now marketed sources such as energy drinks and other dietary supplements. This wide use has led to concerns regarding the safety of caffeine and its proposed beneficial role in alertness, performance and energy expenditure and side effects in the cardiovascular system. The question remains "Which dose is safe?", as the population does not appear to adhere to the strict guidelines listed on caffeine consumption. Studies in humans and animal models yield controversial results, which can be explained by population, type and dose of caffeine and low statistical power. This review will focus on comprehensive and critical review of the current literature and provide an avenue for further study.
Bogomolets National Medical University Kiev Ukraine
Cardiology Center Medika St Petersburg Russia
Division of Clinical Nutrition Faculty of Home Economics Kyoritsu Women's University Tokyo Japan
Faculty of Military Health Sciences University of Defence Hradec Kralove Czech Republic
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc17024145
- 003
- CZ-PrNML
- 005
- 20170831120126.0
- 007
- ta
- 008
- 170720s2016 gw f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1007/s00394-016-1179-z $2 doi
- 035 __
- $a (PubMed)26932503
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a gw
- 100 1_
- $a Zulli, Anthony $u Centre for Chronic Disease (CCD), College of Health and Biomedicine, Victoria University, Melbourne, VIC, Australia.
- 245 10
- $a Caffeine and cardiovascular diseases: critical review of current research / $c A. Zulli, RM. Smith, P. Kubatka, J. Novak, Y. Uehara, H. Loftus, T. Qaradakhi, M. Pohanka, N. Kobyliak, A. Zagatina, J. Klimas, A. Hayes, G. La Rocca, M. Soucek, P. Kruzliak,
- 520 9_
- $a Caffeine is a most widely consumed physiological stimulant worldwide, which is consumed via natural sources, such as coffee and tea, and now marketed sources such as energy drinks and other dietary supplements. This wide use has led to concerns regarding the safety of caffeine and its proposed beneficial role in alertness, performance and energy expenditure and side effects in the cardiovascular system. The question remains "Which dose is safe?", as the population does not appear to adhere to the strict guidelines listed on caffeine consumption. Studies in humans and animal models yield controversial results, which can be explained by population, type and dose of caffeine and low statistical power. This review will focus on comprehensive and critical review of the current literature and provide an avenue for further study.
- 650 _2
- $a zvířata $7 D000818
- 650 _2
- $a cévy $x účinky léků $x metabolismus $7 D001808
- 650 _2
- $a kofein $x aplikace a dávkování $x škodlivé účinky $7 D002110
- 650 _2
- $a kardiovaskulární nemoci $x epidemiologie $7 D002318
- 650 _2
- $a klinická studie jako téma $7 D000068456
- 650 _2
- $a káva $x škodlivé účinky $x chemie $7 D003069
- 650 _2
- $a modely nemocí na zvířatech $7 D004195
- 650 _2
- $a vztah mezi dávkou a účinkem léčiva $7 D004305
- 650 _2
- $a srdce $x účinky léků $x fyziologie $7 D006321
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a metaanalýza jako téma $7 D015201
- 650 _2
- $a metabolický syndrom $x epidemiologie $7 D024821
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a přehledy $7 D016454
- 700 1_
- $a Smith, Renee M $u Centre for Chronic Disease (CCD), College of Health and Biomedicine, Victoria University, Melbourne, VIC, Australia.
- 700 1_
- $a Kubatka, Peter $u Department of Medical Biology, Jessenius Faculty of Medicine, Comenius University in Bratislava, Martin, Slovakia.
- 700 1_
- $a Novak, Jan $u 2nd Department of Internal Medicine, St. Anne's University Hospital and Masaryk University, Brno, Czech Republic. Department of Physiology, Masaryk University, Brno, Czech Republic.
- 700 1_
- $a Uehara, Yoshio $u Division of Clinical Nutrition, Faculty of Home Economics, Kyoritsu Women's University, Tokyo, Japan.
- 700 1_
- $a Loftus, Hayley $u Centre for Chronic Disease (CCD), College of Health and Biomedicine, Victoria University, Melbourne, VIC, Australia.
- 700 1_
- $a Qaradakhi, Tawar $u Centre for Chronic Disease (CCD), College of Health and Biomedicine, Victoria University, Melbourne, VIC, Australia.
- 700 1_
- $a Pohanka, Miroslav $u Faculty of Military Health Sciences, University of Defence, Hradec Kralove, Czech Republic.
- 700 1_
- $a Kobyliak, Nazarii $u Bogomolets National Medical University, Kiev, Ukraine.
- 700 1_
- $a Zagatina, Angela $u Cardiology Center Medika, St. Petersburg, Russia.
- 700 1_
- $a Klimas, Jan $u Department of Pharmacology and Toxicology, Faculty of Pharmacy, Comenius University, Odborarov 10, 832 32, Bratislava, Slovak Republic.
- 700 1_
- $a Hayes, Alan $u Centre for Chronic Disease (CCD), College of Health and Biomedicine, Victoria University, Melbourne, VIC, Australia.
- 700 1_
- $a La Rocca, Giampiero $u Human Anatomy Section, Department of Experimental Biomedicine and Clinical Neurosciences, University of Palermo, Palermo, Italy. Euro-Mediterranean Institute of Science and Technology (IEMEST), Palermo, Italy.
- 700 1_
- $a Soucek, Miroslav $u 2nd Department of Internal Medicine, St. Anne's University Hospital and Masaryk University, Brno, Czech Republic.
- 700 1_
- $a Kruzliak, Peter $u Laboratory of Structural Biology and Proteomics, Faculty of Pharmacy, University of Veterinary and Pharmaceutical Sciences, Palackeho tr 1/1946, Brno, 612 42, Czech Republic. kruzliakpeter@gmail.com.
- 773 0_
- $w MED00005725 $t European journal of nutrition $x 1436-6215 $g Roč. 55, č. 4 (2016), s. 1331-43
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/26932503 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20170720 $b ABA008
- 991 __
- $a 20170831120716 $b ABA008
- 999 __
- $a ok $b bmc $g 1239826 $s 985058
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2016 $b 55 $c 4 $d 1331-43 $e 20160301 $i 1436-6215 $m European journal of nutrition $n Eur J Nutr $x MED00005725
- LZP __
- $a Pubmed-20170720